WaferGen Expects to Report Sharp Increase in Q4 Revenues | GenomeWeb

NEW YORK (GenomeWeb) - WaferGen Biosystems announced this morning that its preliminary, unaudited fourth quarter 2015 revenues rose sharply year over year, driven mainly by sales of its existing SmartChip products

The company says it expects its revenues for Q4 2015 to be in the range of $2.3 million to $2.5 million, which would represent an increase of between 43 percent and 55 percent when compared to the $1.6 million it reported for the same quarter in 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.